CMLHope.Com
A Worldwide Support Network For Chronic Myelogenous Leukemia
Posted by rob on September 20, 2007 under Uncategorized | Be the First to Comment
Sustained remissions and low rate of BCR-ABL resistance mutations with imatinib treatment chronic myelogenous leukemia in patients treated in late chronic phase: A 5-year follow up.
Relapsed acute myelogenous leukemia occurring after 18 years with recurrent novel chromosomal abnormality t(18;22)(q23;q11.2).
You must be logged in to post a comment.
Add A Comment
You must be logged in to post a comment.